World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
19347
World Ranking
18516
National Ranking
9229

Overview

Kim M. Olthoff is affiliated with the University of Pennsylvania in the United States and has published extensively in the field of medicine, with a primary focus on surgery and hepatology. Their research covers topics related to organ transplantation techniques and outcomes, liver disease and transplantation, and organ donation and transplantation.

Olthoff's publication record includes 149 works in medicine, with 43 publications in surgery and 43 in hepatology. Additional areas of study include public health, environmental and occupational health (25 publications), epidemiology (18 publications), and transplantation (10 publications).

Their main topics of research encompass the following:

  • Organ Transplantation Techniques and Outcomes
  • Liver Disease and Transplantation
  • Organ Donation and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Renal Transplantation Outcomes and Treatments
  • Transplantation: Methods and Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis

Kim M. Olthoff has collaborated frequently with several scientific peers, including:

  • Abraham Shaked
  • Elizabeth A. Pomfret
  • Julie K. Heimbach
  • Peter L. Abt
  • Therese Bittermann

Their work has been published in leading transplantation and surgery journals, with frequent contributions to:

  • American Journal of Transplantation
  • Liver Transplantation
  • Annals of Surgery
  • Clinical Transplantation
  • Transplantation

Recent papers include:

  • Fontan-Associated Liver Disease (2020), published in Circulation
  • Advances in resection and transplantation for hepatocellular carcinoma (2020), published in Journal of Hepatology
  • Quantifying Sex-Based Disparities in Liver Allocation (2020), published in JAMA Surgery
  • When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts (2020), published in Transplantation
  • Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH (2021), published in Hepatology

Best Publications

  • Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors

    Kim M. Olthoff;Laura Kulik;Benjamin Samstein;Mary Kaminski

  • Donor morbidity after living donation for liver transplantation.

    Rafik M. Ghobrial;Chris E. Freise;James F. Trotter;Lan Tong

  • Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade

    Nobuhiro Nakamoto;Hyosun Cho;Hyosun Cho;Abraham Shaked;Kim Olthoff

  • Survival Following Liver Transplantation From Non-Heart-Beating Donors

    Peter L. Abt;Niraj M. Desai;Michael D. Crawford;Lisa M. Forman

  • Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications.

    Peter Abt;Michael Crawford;Niraj Desai;James Markmann

  • Outcomes of 385 Adult-to-Adult Living Donor Liver Transplant Recipients: A Report From the A2ALL Consortium

    Kim M. Olthoff;Robert M. Merion;Rafik M. Ghobrial;Michael M. Abecassis

  • Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization

    Nobuhiro Nakamoto;Nobuhiro Nakamoto;David E. Kaplan;David E. Kaplan;Jennifer Coleclough;Jennifer Coleclough;Yun Li;Yun Li

  • Endoscopic management of postoperative biliary complications in orthotopic liver transplantation

    Patrick R. Pfau;Michael L. Kochman;James D. Lewis;William B. Long

  • Complications of living donor hepatic lobectomy--a comprehensive report.

    M. M. Abecassis;R. A. Fisher;K. M. Olthoff;C. E. Freise

  • Treatment of PTLD with Rituximab or Chemotherapy

    R.L. Elstrom;C. Andreadis;N.A. Aqui;V.N. Ahya

  • Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

    R. A. Fisher;L. M. Kulik;C. E. Freise;A. S F Lok

  • Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma

    Valeria R. Mas;Daniel G. Maluf;Kellie J. Archer;Kenneth Yanek

  • Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort Study

    C. E. Freise;B. W. Gillespie;A. J. Koffron;A. S F Lok

  • HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.

    M. E. Roland;B. Barin;L. Carlson;L. A. Frassetto

  • Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.

    Kirti Shetty;Kate Timmins;Colleen Brensinger;Emma E. Furth

  • Guidelines for the referral and management of patients eligible for solid organ transplantation.

    Theodore I. Steinman;Bryan N. Becker;Adaani E. Frost;Kim M. Olthoff

  • Is Liver Transplantation Justified for the Treatment of Hepatic Malignancies

    Kim M. Olthoff;J. Michael Millis;Michael H. Rosove;Leonard I. Goldstein

  • Liver transplantation in children.

    R W Busuttil;P Seu;J M Millis;K M Olthoff

  • The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.

    David Imagawa;J. Millis;Philip Seu;Kim Olthoff

  • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

    Norah A. Terrault;Michelle E. Roland;Thomas Schiano;Lorna Dove

Frequent Co-Authors

Abraham Shaked
Abraham Shaked University of Pennsylvania
Ronald W. Busuttil
Ronald W. Busuttil University of California, Los Angeles
James F. Markmann
James F. Markmann Harvard University
Emma E. Furth
Emma E. Furth University of Pennsylvania
Robert A. Fisher
Robert A. Fisher Beth Israel Deaconess Medical Center
K. Rajender Reddy
K. Rajender Reddy University of Pennsylvania
Jason D. Christie
Jason D. Christie University of Pennsylvania
Jean C. Emond
Jean C. Emond Columbia University
Michael C. Soulen
Michael C. Soulen University of Pennsylvania
Robert M. Merion
Robert M. Merion University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine goes beyond becoming a doctor—numerous rewarding roles exist across the healthcare field, many offering flexible, online study options. For those interested in administrative roles, medical billing and coding schools online provide convenient ways to gain in-demand skills for essential support positions in hospitals and clinics.

If you aspire to patient care, various nursing programs make entering the field more accessible. Some students prefer a nursing school that does not require teas test, eliminating a common admissions hurdle. Registered nurses looking to advance further often consider rn to fnp programs to become Family Nurse Practitioners through structured bridge pathways.

Leadership roles are also in high demand. For those interested in rapid career growth, an accelerated healthcare administration degree online can quickly open doors to management positions within healthcare organizations.

Whether you are considering clinical or administrative paths, these online programs offer flexible options to begin or advance your career in medicine and healthcare.

Best Scientists Citing Kim M. Olthoff

Trending Scientists

Recently Published Articles